COMPANY

VST Bio

HQ: San Diego, CA source · vst-bio.com ↗

Keywords: cardiovascular cardiovascular diseases stroke acute myocardial infarction antibody

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $31.89M (Form D filed Nov 18, 2025; amended Apr 24, 2026). SEC Form D 0001231919-25-000520 (Nov 18, 2025)
Evidence (1 event)
- Nov 18, 2025 · SEC Form D 0001231919-25-000520
  Name of Issuer: VST BIO Corp; CIK: 2093250; Address: San Diego, CA; Submission type: D; Filing date: 2025-11-18; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 28888146; Total Amount Sold: 28888146; Federal exemptions: 06b || Name of Issuer: VST BIO Corp; CIK: 2093250; Address: San Diego, CA; Submission type: D/A; Filing date: 2026-04-24; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 31888146; Total Amount Sold: 31888146; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals